Warning! GuruFocus detected
5 Severe warning signs
with CBI.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Clal Biotechnology Industries Ltd
ISIN : IL0011042806
Description
Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.41 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.39 | |||||
| Debt-to-EBITDA | 0.58 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -9.12 | |||||
| Beneish M-Score | -2.88 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 86.7 | |||||
| 3-Year FCF Growth Rate | 37.9 | |||||
| 3-Year Book Growth Rate | -30.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.54 | |||||
| 9-Day RSI | 26.66 | |||||
| 14-Day RSI | 31.15 | |||||
| 3-1 Month Momentum % | -2.28 | |||||
| 6-1 Month Momentum % | -6.79 | |||||
| 12-1 Month Momentum % | -18.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.18 | |||||
| Quick Ratio | 2.18 | |||||
| Cash Ratio | 2.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.9 | |||||
| Shareholder Yield % | -14.59 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -25396.88 | |||||
| Net Margin % | -233553.13 | |||||
| FCF Margin % | -25159.38 | |||||
| ROE % | -76.36 | |||||
| ROA % | -48.67 | |||||
| ROIC % | -5.65 | |||||
| 3-Year ROIIC % | -0.17 | |||||
| ROC (Joel Greenblatt) % | 1070.24 | |||||
| ROCE % | 26.69 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 304 | |||||
| PB Ratio | 0.79 | |||||
| Price-to-Tangible-Book | 0.76 | |||||
| EV-to-EBIT | 2.12 | |||||
| EV-to-EBITDA | 2.1 | |||||
| EV-to-Revenue | 2624.29 | |||||
| EV-to-FCF | -11.11 | |||||
| Price-to-GF-Value | 0.35 | |||||
| Price-to-Median-PS-Value | 14.45 | |||||
| Earnings Yield (Greenblatt) % | 47.11 | |||||
| FCF Yield % | -17.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Clal Biotechnology Industries Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | 0.032 | ||
| EPS (TTM) (₪) | -0.48 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.93 | ||
| 3-Year Sortino Ratio | -1.13 | ||
| Volatility % | 44.63 | ||
| 14-Day RSI | 31.15 | ||
| 14-Day ATR (₪) | 0.011223 | ||
| 20-Day SMA (₪) | 0.3383 | ||
| 12-1 Month Momentum % | -18.72 | ||
| 52-Week Range (₪) | 0.29 - 0.53 | ||
| Shares Outstanding (Mil) | 156.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Clal Biotechnology Industries Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Clal Biotechnology Industries Ltd Stock Events
| Event | Date | Price (₪) | ||
|---|---|---|---|---|
| No Event Data | ||||
Clal Biotechnology Industries Ltd Frequently Asked Questions
What is Clal Biotechnology Industries Ltd(XTAE:CBI)'s stock price today?
The current price of XTAE:CBI is ₪0.29. The 52 week high of XTAE:CBI is ₪0.53 and 52 week low is ₪0.29.
When is next earnings date of Clal Biotechnology Industries Ltd(XTAE:CBI)?
The next earnings date of Clal Biotechnology Industries Ltd(XTAE:CBI) is .
Does Clal Biotechnology Industries Ltd(XTAE:CBI) pay dividends? If so, how much?
Clal Biotechnology Industries Ltd(XTAE:CBI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers